Security Snapshot

Connect Biopharma Holdings Ltd - Ordinary Shares (CNTB) Institutional Ownership

CUSIP: G23549101

13F Institutional Holders and Ownership History from Q3 2025 to Q4 2025

Latest Period

Q4 2025

Institutions Reporting

28

Shares (Excl. Options)

8,464,921

Price

$2.82

Type / Class
Equity / Ordinary Shares
Symbol
CNTB on Nasdaq
Shares outstanding
62,075,472
Price per share
$2.80
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
8,464,921
Total reported value
$23,870,814
% of total 13F portfolios
0%
Share change
+7,689,504
Value change
+$21,721,782
Number of holders
28
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Sponsored

Quick Takeaways

  • CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares is tracked under CUSIP G23549101.
  • 28 institutions reported positions in Q4 2025.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 15 to 28 between Q3 2025 and Q4 2025.
  • Reported value moved from $2,443,403 to $23,870,814.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Official SEC Source

Backed by Form 13F

Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.

See Original Filing

Investment Quick Answers

What is CUSIP G23549101?
CUSIP G23549101 identifies CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Connect Biopharma Holdings Ltd - Ordinary Shares (CNTB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Panacea Innovation Ltd 21% -1.4% $36,848,000 +$3,248,000 13,160,000 +9.7% Panacea Innovation Limited 31 Mar 2026

As of 31 Dec 2025, 28 institutional investors reported holding 8,464,921 shares of Connect Biopharma Holdings Ltd - Ordinary Shares (CNTB). This represents 14% of the company’s total 62,075,472 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Connect Biopharma Holdings Ltd - Ordinary Shares (CNTB) together control 14% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Ikarian Capital, LLC 7.7% 4,788,486 1.8% $13,503,531
BOOTHBAY FUND MANAGEMENT, LLC 2% 1,234,582 0.09% $3,481,521
PERCEPTIVE ADVISORS LLC 1.3% 792,696 0.04% $2,235,403
BML Capital Management, LLC 0.66% 408,887 0% 1% $1,153,061
Knott David M Jr 0.32% 200,000 0.26% $564,000
Richmond Brothers, Inc. 0.28% 173,485 0.31% $489,228
RENAISSANCE TECHNOLOGIES LLC 0.23% 143,100 -9.5% 0% $403,542
MARSHALL WACE, LLP 0.21% 128,368 +121% 0% $361,998
CITADEL ADVISORS LLC 0.16% 99,493 0% $280,570
JANE STREET GROUP, LLC 0.13% 82,226 0% $231,877
OMERS ADMINISTRATION Corp 0.13% 80,808 0% $227,879
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.12% 71,503 +420% 0% $201,638
Koa Wealth Management, LLC 0.08% 49,600 0% 0.1% $139,872
MILLENNIUM MANAGEMENT LLC 0.08% 47,050 0% $132,681
ROYAL BANK OF CANADA 0.07% 40,400 0% $114,000
Persistent Asset Partners Ltd 0.04% 26,774 0.04% $75,503
GEODE CAPITAL MANAGEMENT, LLC 0.04% 23,320 0% 0% $65,762
HRT FINANCIAL LP 0.03% 16,785 +61% 0% $47,000
Point72 Asset Management, L.P. 0.03% 16,503 0% $46,538
SmartHarvest Portfolios, LLC 0.02% 12,897 0% 0.01% $36,370
MONOGRAPH WEALTH ADVISORS, LLC 0.02% 11,130 0% 0% $31,387
Qube Research & Technologies Ltd 0.02% 10,449 0% $29,466
UBS Group AG 0.01% 3,165 +1475% 0% $8,925
MORGAN STANLEY 0% 2,209 +2109% 0% $6,229
RHUMBLINE ADVISERS 0% 780 0% 0% $2,199

Institutional Holders of Connect Biopharma Holdings Ltd - Ordinary Shares (CNTB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 8,464,921 $23,870,814 +$21,721,782 $2.82 28
2025 Q3 1,621,133 $2,443,403 +$2,443,403 $1.48 15